Work

Abstract 4436: Sutro’s site-specific dual-payload ADCs combining TOPO1i and DNA damage response inhibitors to enhance efficacy, overcome resistance, and improve safety

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-4436

Authors: Krishna Bajjuri, Robert Yuan, Daniel Calarese, Rhoneil Pena, Ravi Singh, Young Park, Cuong Tran, Abigail Yu, Xiaofan Li, Guifen Xu, Yihong Zhou, Brian Vuillemenot, Werner Rubas, Genevive Hernandez, Alice Yam, Gang Yin, Hans-Peter Gerber

Institution: Sutro Biopharma (United States)

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148722865

Cites:

Cited by: 1

Related to: